Advanstar reports first-half revenues up 13%

Share this article:
Advanstar reported first-half revenues up 13% year-on-year, from $146 million to $165 million--though its life sciences division was nearly flat for Q2. Revenues from Advanstar life sciences properties rose by 3% for the period, as overall revenues rose 6%, largely on a 24% jump in the firm's power sports division. 
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.